Ziagen and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Ziagen (abacavir sulfate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Epivir, and have Agranulocytosis.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Ziagen. It is created by eHealthMe based on reports of 7,602 people who have side effects when taking Ziagen from the FDA, and is updated regularly.

What is Ziagen?

Ziagen has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 7,626 Ziagen users. Check the latest studies of Ziagen.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,504 drugs and 1,886 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Apr, 18, 2026

7,602 people reported to have side effects when taking Ziagen.
Among them, 18 people (0.24%) have Visual acuity reduced.

Could Ziagen cause Visual acuity reduced?

Among these 18 people:

How long have people been on Ziagen when they have Visual acuity reduced? *

What is the gender of people who have Visual acuity reduced when taking Ziagen? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Visual acuity reduced when taking Ziagen? *

What are other drugs people take besides Ziagen? *

What are other side effects people have besides Visual acuity reduced? *

Cd4 Lymphocytes Decreased: 4 people, 22.22%
Injection Site Reaction: 3 people, 16.67%
Acute Kidney Failure: 3 people, 16.67%
Itching: 3 people, 16.67%
Injection Site Haemorrhage (bleeding from injection site): 3 people, 16.67%
Blood Hiv Rna Increased: 3 people, 16.67%
Cyst (a closed sac): 3 people, 16.67%
Abdominal Pain Upper: 2 people, 11.11%
Nodule (a growth of abnormal tissue): 2 people, 11.11%
Injection Site Pain: 2 people, 11.11%

What are the existing conditions these people have? *

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 1 person, 5.56%
Ill-Defined Disorder: 1 person, 5.56%
Hiv Test Positive: 1 person, 5.56%
High Blood Pressure: 1 person, 5.56%
High Blood Cholesterol: 1 person, 5.56%
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi): 1 person, 5.56%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Ziagen and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ziagen:

Ziagen (7,626 reports)

Browse all side effects of Ziagen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,504 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,886 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on abacavir sulfate (the active ingredients of Ziagen) and Ziagen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.